169 related articles for article (PubMed ID: 38612755)
1. Dichotomous Effects of Glypican-4 on Cancer Progression and Its Crosstalk with Oncogenes.
Chérouvrier Hansson V; Cheng F; Georgolopoulos G; Mani K
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612755
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract][Full Text] [Related]
3. Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells.
Cao J; Ma J; Sun L; Li J; Qin T; Zhou C; Cheng L; Chen K; Qian W; Duan W; Wang F; Wu E; Wang Z; Ma Q; Han L
J Cell Biochem; 2018 Nov; 119(11):9498-9512. PubMed ID: 30010221
[TBL] [Abstract][Full Text] [Related]
4. Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer.
Muendlein A; Heinzle C; Brandtner EM; Leiherer A; Drexel H; Dechow T; Decker T
Oncol Res Treat; 2023; 46(4):151-156. PubMed ID: 36750040
[TBL] [Abstract][Full Text] [Related]
5. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma.
Zhao D; Liu S; Sun L; Zhao Z; Liu S; Kuang X; Shu J; Luo B
Virus Res; 2016 Jul; 220():52-6. PubMed ID: 27071854
[TBL] [Abstract][Full Text] [Related]
6. miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma.
Sun Y; Zhao J; Yin X; Yuan X; Guo J; Bi J
Cell Prolif; 2016 Oct; 49(5):636-43. PubMed ID: 27554041
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic Variants in GPC4 Cause Keipert Syndrome.
Amor DJ; Stephenson SEM; Mustapha M; Mensah MA; Ockeloen CW; Lee WS; Tankard RM; Phelan DG; Shinawi M; de Brouwer APM; Pfundt R; Dowling C; Toler TL; Sutton VR; Agolini E; Rinelli M; Capolino R; Martinelli D; Zampino G; Dumić M; Reardon W; Shaw-Smith C; Leventer RJ; Delatycki MB; Kleefstra T; Mundlos S; Mortier G; Bahlo M; Allen NJ; Lockhart PJ
Am J Hum Genet; 2019 May; 104(5):914-924. PubMed ID: 30982611
[TBL] [Abstract][Full Text] [Related]
8. Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.
Muendlein A; Severgnini L; Decker T; Heinzle C; Leiherer A; Geiger K; Drexel H; Winder T; Reimann P; Mayer F; Nonnenbroich C; Dechow T
Front Oncol; 2022; 12():1045995. PubMed ID: 36353562
[TBL] [Abstract][Full Text] [Related]
9. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma.
Aviel-Ronen S; Lau SK; Pintilie M; Lau D; Liu N; Tsao MS; Jothy S
Mod Pathol; 2008 Jul; 21(7):817-25. PubMed ID: 18469798
[TBL] [Abstract][Full Text] [Related]
10.
Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
[TBL] [Abstract][Full Text] [Related]
11. Glypican4 promotes cardiac specification and differentiation by attenuating canonical Wnt and Bmp signaling.
Strate I; Tessadori F; Bakkers J
Development; 2015 May; 142(10):1767-76. PubMed ID: 25968312
[TBL] [Abstract][Full Text] [Related]
12. [Expression of glypican-3 in lung squamous cell carcinoma and adenocarcinoma and its relation with prognosis].
Li H; Deng Q; Huang L; Tang H; Cheng X
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):212-5. PubMed ID: 23443774
[TBL] [Abstract][Full Text] [Related]
13. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance.
Yu X; Li Y; Chen SW; Shi Y; Xu F
Genet Mol Res; 2015 Aug; 14(3):10185-92. PubMed ID: 26345955
[TBL] [Abstract][Full Text] [Related]
15. Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.
Muendlein A; Heinzle C; Leiherer A; Brandtner EM; Geiger K; Gaenger S; Fraunberger P; Mader A; Saely CH; Drexel H
Clin Biochem; 2023 Nov; 121-122():110675. PubMed ID: 37844682
[TBL] [Abstract][Full Text] [Related]
16. Expression of Glypican-4 in the brains of epileptic patients and epileptic animals and its effects on epileptic seizures.
Xiong Y; Zhang Y; Zheng F; Yang Y; Xu X; Wang W; Zhu B; Wang X
Biochem Biophys Res Commun; 2016 Sep; 478(1):241-246. PubMed ID: 27425250
[TBL] [Abstract][Full Text] [Related]
17. Glypican-6 and Glypican-4 stimulate embryonic stomach growth by regulating Hedgehog and noncanonical Wnt signaling.
Shi W; Filmus J
Dev Dyn; 2022 Dec; 251(12):2015-2028. PubMed ID: 36057966
[TBL] [Abstract][Full Text] [Related]
18. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
20. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
